Vyant Bio Inc
VYNT | $0.194 -8.51% 19K
|
Health Care and Social Assistan...
(0.0% 1d) (0.0% 1m) (-43.7% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (1671.02% volume)
Earnings Calendar: 2023-03-29
Market Cap: $ 1,227,778
https://www.vyantbio.com
Sec Filling | Patents | n/a employees
(US) Vyant Bio operates two wholly-owned subsidiaries, StemoniX and vivoPharm. The Company will immediately begin to execute on the integration of these two leading businesses, to converge human-powered scientific and technology-based systems and expertise with years of preclinical experience to de-risk and accelerate discovery and development of preclinical and clinical pipelines for biopharma partners as well as for the proprietary pipeline of the Company.
add to watch list Paper trade email alert is off
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 46% | 54% |
Top 10 Gainers
SGBX | $0.26 80.43% 54M
|
Producer Manufacturing
LICN | $1.0 78.57% 3.3M
|
CSSE 4 | $0.2656 74.39% 9.7M
|
Consumer Services
BRFH 4 | $1.89 71.82% 32M
|
Manufacturing
ACON | $0.49 70.14% 24M
|
n/a
BOF | $1.95 66.67% 920K
|
MTC | $3.62 61.61% 790K
|
Technology Services
AMST | $3.22 61.0% 720K
|
Technology Services
PCSA | $2.28 40.74% 37M
|
Producer Manufacturing
EVA | $0.626 39.14% 2.3M
|
Process Industries
Last 48 Hours Insiders Buying
TPL P 3 | $580.0 -1.53% 3.9K
|
Miscellaneous
|
14:30
MNSB P 1470 | $15.38 -3.21% 3.9K
|
Finance
|
12:00
RKT P 347 | $11.815 -5.86% 270K
|
Finance
|
22:30
NWFL | News | $24.21 55
|
Finance
|
22:00
TGEN P 10000 | $0.68 20K
|
Utilities
|
20:01
RMCF | $3.51 -1.13% 20
|
Consumer Non-Durables
|
20:10